Search

Looking for viruses in your microbiome data? KBase has new Apps to identify and analyze viral sequences in your assemblies. Join this webinar on Nov. 4 at 1pm ET/10am PT to learn the basics of viral analysis in KBase from Dr. Ben Bolduc of

Patients in India in need of phage therapy used to have to ship their samples internationally for phage susceptibility testing, which was a dealbreaker for even phage-friendly doctors as this was slow and expensive. Now, they can do it loca

Dutch phage biotech company Micreos has signed a license agreement with L'Oréal — this means L'Oréal can incorporate Micreos' phage lysins into its products, and represents a huge milestone for phage biotech making its way into the mainstre

There is currently no working treatment for recurring bacterial vaginosis (BV). Christine Landlinger (PhagoMed Biopharma GmbH) and colleagues published a new preprint in medRxiv showing that their engineered phage endolysin candidate elimin

Long-read genome sequencing suffers from high DNA requirements and sequencing errors, so Olivier Zablocki (Ohio State University) and colleagues developed VirION2, an integrated short- and long-read metagenomic wet-lab and informatics pipel

Do you consider a virus-like particle (VLP) to be a particle that looks like a virus, or is it a virus specifically lacking a viral genome? Different fields (e.g. ecology vs. vaccine development) use the term differently. Paul Hyman, Gary T

PHAVES #10 will be a seminar by Dr. Paul Jaschke, Assistant Professor at Macquarie University, Australia, on Nov. 10, 5:30 PM Eastern Time (GMT-4) / Nov. 11 at 9:30 AM AEST. His talk is entitled "Learning How to Engineer Genomes by Building

Adaptive Phage Therapeutics (APT) has received Orphan drug designation from the FDA for the use of its PhageBank™ (a continually expanding library of phages) to treat prosthetic joint infections. APT will now be eligible for seven years of

The FDA has authorized Armata Pharmaceuticals to initiate a phase 1b/2a clinical trial, which they are calling "SWARM-P.a.", to test AP-PA02, its lead phage cocktail candidate, against Pseudomonas aeruginosa airway infections in cystic fibr

Vivek Mutalik (Lawrence Berkeley National Lab) and colleagues published their method of high-throughput mapping of the phage resistance landscape in E. coli in PLoS Biology. Sound familiar? We highlighted this paper's corresponding preprint

As there is currently no gold standard for developing a phage cocktail, Melissa Haines (University of Leicester, UK) and colleagues set out to describe a novel approach to phage cocktail development by comparing different methods side by si

Before now, only eight phages and two archaeal viruses had been isolated from deep sea vents. Sarah Thiroux (Université de Bretagne Occidentale, France) and colleagues published a new paper describing another: the first head‐tailed virus in

Eveline-Marie Lammens (KU Leuven) and colleagues published a new perspective in Nature Communications that explores the synthetic biology potential of phages for engineering non-model bacteria.

PHAVES #10 will be a seminar by Dr. Paul Jaschke, Assistant Professor at Macquarie University, Australia, on Nov. 10, 5:30 PM Eastern Time (GMT-4) / Nov. 11 at 9:30 AM AEST. His talk is entitled "Learning How to Engineer Genomes by Building

PHAVES #10 will be a seminar by Dr. Paul Jaschke, Assistant Professor at Macquarie University, Australia, on Nov. 10, 5:30 PM Eastern Time (GMT-4) / Nov. 11 at 9:30 AM AEST. His talk is entitled "Learning How to Engineer Genomes by Building

The phage research community sadly lost one of its greats this month; Dr. Richard Calendar passed away on October 10 following a long battle with prostate cancer. Rich, as he was known to many, was a renowned UC Berkeley Professor of Molec

It's World Phage Week (Oct 22-28)! Check out Twitter (#WorldPhageWeek) for lots of fun posts from the global phage community showcasing fun phage facts, great phage images and art, favourite papers, exciting milestones and more.

The Ibadan Bacteriophage Research Team (IBRT) is hosting a series of webinars Oct 26-27 to celebrate World Phage Week! Theme: "Early Career Research in Bacteriophage Studies: A leverage for Bacteriophage Therapy Advancement". Speakers: Prof

Dr. Jason Gill (Center for Phage Technology, Texas A&M) and Dr. Paul Turner (Yale University) will discuss their work on phage therapy to treat drug resistant bacterial infections in a free webinar hosted by The Scientist on Oct 29 from 2:3

The Ibadan Bacteriophage Research Team is hosting a series of webinars to celebrate International Phage Week at the end of the month! Talks will take place Oct 26 and 27. The theme will be "Early Career Research in Bacteriophage Studies: A